Search results (6)
« Back to PublicationsMutant TDP-43 drives impairments in axonal transport and glycolysis in a mouse stem-cell-derived motor neuron model of amyotrophic lateral sclerosis (ALS)
Carroll E. et al, (2026), Cell Death and Disease, 17
Recent developments in gene therapy for Parkinson's disease
Szunyogh S. et al, (2025), Molecular Therapy
Drug repurposing in amyotrophic lateral sclerosis (ALS)
Carroll E. et al, (2025), Expert Opinion on Drug Discovery
Dynactin-1 mediates rescue of impaired axonal transport due to reduced mitochondrial bioenergetics in amyotrophic lateral sclerosis motor neurons
Dafinca R. et al, (2024), Brain Communications, 6
C9orf72-ALS human iPSC microglia are pro-inflammatory and toxic to co-cultured motor neurons via MMP9
Vahsen BF. et al, (2023), Nature Communications, 14
Targeting phosphoglycerate kinase 1 with terazosin improves motor neuron phenotypes in multiple models of amyotrophic lateral sclerosis
Chaytow H. et al, (2022), eBioMedicine, 83